Issue

Vol. 35 No. 12 (2023): Vol 35 Issue 12, 2023

Copyright (c) 2023 Dipesh Kumar Sharma, Surabhi Singh

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Evaluation of Cytotoxicity of 1H-1,2,4-Triazole-3-carboxamide Derivatives in Various Cancer Cell Lines using MTT Assay: Synthesis, Characterization and Molecular Docking Studies

https://doi.org/10.14233/ajchem.2023.29062
Dipesh Kumar Sharma
School of Basic and Applied Sciences, Career Point University, Kota-325003, India
Surabhi Singh
School of Basic and Applied Sciences, Career Point University, Kota-325003, India

Asian Journal of Chemistry, Vol. 35 No. 12 (2023): Vol 35 Issue 12, 2023

Abstract

The pursuit of discovering efficacious novel anticancer agents is an ongoing and perpetual endeavour. The ongoing research endeavour involves the discovery of a new set of various substituted 1,2,4-triazole carboxamide derivatives. The synthetic process involves multiple steps: converting thiooxamic acid ethyl ester to ethyl b-N-boc-oxalamidrazone (2), preparing ethyl esters of 5-substituted 1,2,4-triazole-3-carboxylic acid (3) and synthesizing 5-substituted 1,2,4-triazole-3-carboxylic acid amides (4a-n) using potassium tert.-butoxide. The resulting compounds are characterized using 1H and 13C NMR spectroscopy and HRMS. Molecula  docking experiments were performed using the synthesized compounds against two cancer targets, viz. EGFR (6LUD) and CDK-4 (7SJ3). The compounds were assessed for their anticancer potential against four different cancer cell lines, namely non-small cell lung cancer (A-549), pancreatic cancer (PANC-1), colorectal cancer (HCT-116) and cervical cancer (HaLa) cell lines. Additionally, a normal human embryonic kidney cell line (HEK-293) was used for comparison. The results obtained from molecular docking analysis demonstrated that the 1,2,4-triazole carboxamides (4c, 4e, 4h, 4m and 4n) exhibited more favourable binding interactions compared to the ligands that were co-crystallized. All the compounds exhibited a satisfactory cytotoxicity profile in comparison to the reference drug doxorubicin. Among the compounds that tested, it was observed that compounds 4e and 4m displayed the most pronounced inhibitory activity across all the cell lines that were tested.

Keywords

1,2,4-Triazole Anticancer MTT assay EGFR CDK-4
Sharma, D. K., & Singh, S. (2023). Evaluation of Cytotoxicity of 1H-1,2,4-Triazole-3-carboxamide Derivatives in Various Cancer Cell Lines using MTT Assay: Synthesis, Characterization and Molecular Docking Studies. Asian Journal of Chemistry, 35(12), 2963–2970. https://doi.org/10.14233/ajchem.2023.29062
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. H. Mithoowani and M. Febbraro, Curr. Oncol., 29, 1828 (2022); https://doi.org/10.3390/curroncol29030150
  2. U. Anand, A. Dey, A.K.S. Chandel, R. Sanyal, A. Mishra, D.K. Pandey, V. De Falco, A. Upadhyay, R. Kandimalla, A. Chaudhary, J.K. Dhanjal, S. Dewanjee, J. Vallamkondu and J.M. Pérez de la Lastra, Genes Dis., 10, 1367 (2023); https://doi.org/10.1016/j.gendis.2022.02.007
  3. W.M.C. Van den Boogaard, D.S.J. Komninos and W.P. Vermeij, Cancers, 14, 627 (2022); https://doi.org/10.3390/cancers14030627
  4. R. Kaur, A. Ranjan Dwivedi, B. Kumar and V. Kumar, Anticancer Agents Med. Chem., 16, 465 (2016); https://doi.org/10.2174/1871520615666150819121106
  5. E. Bonandi, M.S. Christodoulou, G. Fumagalli, D. Perdicchia, G. Rastelli and D. Passarella, Drug Discov. Today, 22, 1572 (2017); https://doi.org/10.1016/j.drudis.2017.05.014
  6. J. Murray, O.E. Young, L. Renshaw, S. White, L. Williams, D.B. Evans, J.S. Thomas, M. Dowsett and J.M. Dixon, Breast Cancer Res. Treat., 114, 495 (2009); https://doi.org/10.1007/s10549-008-0027-0
  7. M.I. Han, H. Bekçi, A.I. Uba, Y. Yildirim, E. Karasulu, A. Cumaoglu, H.Y. Karasulu, K. Yelekçi, O. Yilmaz and S.G. Küçükgüzel, Arch. Pharm. (Weinheim), 352, 1800365 (2019); https://doi.org/10.1002/ardp.201800365
  8. R.Z. Batran, D.H. Dawood, S.A. El-Seginy, M.M. Ali, T.J. Maher, K.S. Gugnani and A.N. Rondon-Ortiz, Arch. Pharm., 350, 1700064 (2017); https://doi.org/10.1002/ardp.201700064
  9. M. Qin, S. Yan, L. Wang, H. Zhang, Y. Zhao, S. Wu, D. Wu and P. Gong, Eur. J. Med. Chem., 115, 1 (2016); https://doi.org/10.1016/j.ejmech.2016.02.071
  10. J. Liu, M. Nie, Y. Wang, J. Hu, F. Zhang, Y. Gao, Y. Liu and P. Gong, Eur. J. Med. Chem., 123, 431 (2016); https://doi.org/10.1016/j.ejmech.2016.07.059
  11. S.A. Shahzad, M. Yar, Z.A. Khan, L. Shahzadi, S.A.R. Naqvi, A. Mahmood, S. Ullah, A.J. Shaikh, T.A. Sherazi, A.T. Bale, J. Kuku³owicz and M. Bajda, Bioorg. Chem., 85, 209 (2019); https://doi.org/10.1016/j.bioorg.2019.01.005
  12. H. Bera, B.J. Tan, L. Sun, A.V. Dolzhenko, W.K. Chui and G.N. Chiu, Eur. J. Med. Chem., 67, 325 (2013); https://doi.org/10.1016/j.ejmech.2013.06.051
  13. I.H. Eissa, A.M. Metwaly, A. Belal, A.B.M. Mehany, R.R. Ayyad, K. El-Adl, H.A. Mahdy, M.S. Taghour, K.M.A. El-Gamal, M.E. El-Sawah, S.A. Elmetwally, M.A. Elhendawy, M.M. Radwan and M.A. ElSohly, Arch. Pharm., 352, 1900123 (2019); https://doi.org/10.1002/ardp.201900123
  14. M.K. Ibrahim, M.S. Taghour, A.M. Metwaly, A. Belal, A.B.M. Mehany, M.A. Elhendawy, M.M. Radwan, A.M. Yassin, N.M. El-Deeb, E.E. Hafez, M.A. ElSohly and I.H. Eissa, Eur. J. Med. Chem., 155, 117 (2018); https://doi.org/10.1016/j.ejmech.2018.06.004
  15. Z. Song, Y. Liu, Z. Dai, W. Liu, K. Zhao, T. Zhang, Y. Hu, X. Zhang and Y. Dai, Bioorg. Med. Chem., 24, 4723 (2016); https://doi.org/10.1016/j.bmc.2016.08.014
  16. G. Sáez-Calvo, A. Sharma, F.A. Balaguer, I. Barasoain, M.Á. Berbís, H. Muñoz-Hernández, J. Rodríguez-Salarichs, N. Olieric, S. Wendeborn, M.A. Peñalva, R. Matesanz, Á. Canales, A.E. Prota, J. Jímenez-Barbero, J.M. Andreu, C. Lamberth, M.O. Steinmetz and J.F. Díaz, Cell Chem. Biol., 24, 737 (2017); https://doi.org/10.1016/j.chembiol.2017.05.016
  17. M. Alswah, A.H. Bayoumi, K. Elgamal, A. Elmorsy, S. Ihmaid and H.E.A. Ahmed, Molecules, 23, 48 (2017); https://doi.org/10.3390/molecules23010048
  18. M. Szumilak, A. Wiktorowska-Owczarek and A. Stanczak, Molecules, 26, 2601 (2021); https://doi.org/10.3390/molecules26092601
  19. N. Li, C. Chen, H. zhu, Z. Shi, J. Sun and L. Chen, Bioorg. Chem., 111, 104867 (2021); https://doi.org/10.1016/j.bioorg.2021.104867
  20. L.E. Grebenkina, A.V. Matveev and M.V. Chudinov, Chem. Heterocycl. Compd., 56, 1173 (2020); https://doi.org/10.1007/s10593-020-02794-2
  21. J. Park, Y.J. Yoon, B. Kim, H.G. Lee, S.B. Kang, G. Sung, J.J. Kim and S.G. Lee, Synthesis, 44, e1 (2012); https://doi.org/10.1055/s-0031-1289625
  22. X.Y. Meng, H.X. Zhang, M. Mezei and M. Cui, Curr. Computeraided Drug Des., 7, 146 (2011); https://doi.org/10.2174/157340911795677602
  23. T.L. Riss, R.A. Moravec, A.L. Niles, S. Duellman, H.A. Benink, T.J. Worzella and L. Minor, Cell Viability Assays - Assay Guidance Manual - NCBI Bookshelf, NCBI Bookshelf (2016).
Read More
Author biographies is not available.
Statistic
Read Counter : 0 Download : 0